Pharmacogenomics Market
Pharmacogenomics Market Size, Share & Trends Analysis Report
Pharmacogenomics Market Size, Share & Trends Analysis, By Type (Products {Consumables and Equipment} and Services), By Techniques (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, In-situ Hybridization, and Others), By Application (Personalized Medicine, Drug Discovery, and Others), By Disease (Oncology, Neurology, Cardiology, and Others), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Regional Forecast, 2026-2035
Published
Report ID : BMRC 3825
Number of pages : 300
Published Date : Jun 2026
Category : Pharmaceutical
Delivery Timeline : 48 hrs
Pharmacogenomics Market Segmentation
By Technology
- DNA Sequencing
- Microarray
- Polymerase Chain Reaction (PCR)
- Electrophoresis
- Mass Spectrometry
- Others
By Application
- Cardiovascular Diseases
- Infectious Diseases
- Oncology
- Neurological Diseases
- Pain Management
- Others
By End User
- Hospitals & Clinics
- Research Institutions and Academic Institutes
- Diagnostic Laboratories
- Others
Pharmacogenomics Market Players
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd
- Pharmigene
- Abbott
- Agilent Technologies, Inc.
- QIAGEN
- GE HealthCare
- Empire Genomics, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies plc.
- PerkinElmer Inc.
- Myriad Genetics, Inc.
- Illumina, Inc.
- Macrogen, Inc.
- BGI Genomics
- Eurofins Scientific
- MapMyGenome
- Invitae Corporation
SUMMARY
Segments
Pharmacogenomics Market Segmentation
By Technology
- DNA Sequencing
- Microarray
- Polymerase Chain Reaction (PCR)
- Electrophoresis
- Mass Spectrometry
- Others
By Application
- Cardiovascular Diseases
- Infectious Diseases
- Oncology
- Neurological Diseases
- Pain Management
- Others
By End User
- Hospitals & Clinics
- Research Institutions and Academic Institutes
- Diagnostic Laboratories
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Pharmacogenomics Market Players
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd
- Pharmigene
- Abbott
- Agilent Technologies, Inc.
- QIAGEN
- GE HealthCare
- Empire Genomics, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies plc.
- PerkinElmer Inc.
- Myriad Genetics, Inc.
- Illumina, Inc.
- Macrogen, Inc.
- BGI Genomics
- Eurofins Scientific
- MapMyGenome
- Invitae Corporation
